Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
← Research & Industry News
External source

NSF-backed test bed targets programmable biomanufacturing

A new test bed linked to the University of Maryland and NIST will support programmable, automated manufacturing workflows. The announcement concerns a product, collaboration or production plan; it does not by itself establish clinical benefit or verified scale-up performance.

Published by
GEN — Genetic Engineering & Biotechnology News
Evidence type
Industry

GEN reports: A new test bed linked to the University of Maryland and NIST will support programmable, automated manufacturing workflows.

The announcement concerns a product, collaboration or production plan; it does not by itself establish clinical benefit or verified scale-up performance. Consult the linked GEN report for the source organisation’s full announcement.

Manufacturing & Translation

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through GMP supply.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes, licensing and GMP supply.InvestorsDownload our capabilities deckPlatform, pipeline milestones, manufacturing and partnership models in one PDF.

Prefer to talk it through? Book a 30-minute discovery call

NSF-backed test bed targets programmable biomanufacturing | Brilliant Blue Biosciences